URI
62
3
WFC
74
-5
DHR
62
2
NKE
33
3
IPG
43
5
CINF
45
-2
CTAS
55
-4
PRU
62
2
MHK
52
4
VFC
44
-3
IBM
64
2
HCA
55
-4
MDLZ
36
2
NTRS
69
2
KLAC
67
2
HPE
49
2
IRM
49
-3
AMAT
66
5
NRG
69
-6
FTI
66
2
URI
62
3
WFC
74
-5
DHR
62
2
NKE
33
3
IPG
43
5
CINF
45
-2
CTAS
55
-4
PRU
62
2
MHK
52
4
VFC
44
-3
IBM
64
2
HCA
55
-4
MDLZ
36
2
NTRS
69
2
KLAC
67
2
HPE
49
2
IRM
49
-3
AMAT
66
5
NRG
69
-6
FTI
66
2
Financhill
Back

John Hancock Financial Opportunities Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
67

BTO
John Hancock Financial Opportunities Fund

Last Price:
$35.05
Seasonality Move:
-0.56%
Buy
60

HALO
Halozyme Therapeutics

Last Price:
$55.16
Seasonality Move:
4.55%
Buy
67
John Hancock Financial Opportunities Fund (BTO) is a Buy

Is John Hancock Financial Opportunities Fund a Buy, Sell or Hold?

  • The current John Hancock Financial Opportunities Fund [BTO] share price is $34.97. The Score for BTO is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • BTO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $53.77. The Score for HALO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BTO Stock Price Chart

What is John Hancock Financial Opportunities Fund's stock price today?

  • The John Hancock Financial Opportunities Fund share price today is $34.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BTO is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $53.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BTO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.42 Buy
Relative Strength Index (14 RSI): 64.16 Buy
Chaikin Money Flow: 6103 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.52 - 34.78) Buy
Bollinger Bands (100): (31.82 - 36.56) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.2 Sell
Relative Strength Index (14 RSI): 44.02 Sell
Chaikin Money Flow: -885628 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.26 - 61.44) Sell
Bollinger Bands (100): (54.45 - 62.43) Sell

BTO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.37 Buy
20-day SMA: 34.36 Buy
50-day SMA: 32.71 Buy
200-day SMA: 34.52 Buy
8-day EMA: 34.48 Buy
20-day EMA: 34.11 Buy
50-day EMA: 33.66 Buy
200-day EMA: 33.54 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.35 Sell
20-day SMA: 53.32 Buy
50-day SMA: 58.01 Sell
200-day SMA: 56.25 Sell
8-day EMA: 54.17 Sell
20-day EMA: 55.06 Sell
50-day EMA: 56.88 Sell
200-day EMA: 55.23 Sell

John Hancock Financial Opportunities Fund Earnings Growth & BTO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.

John Hancock Financial Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):